|
The National Institutes of Health (NIH) became interested in vulvodynia towards the late 1990s. The NVA worked together with several NIH Institutes in 1997 to organize and support the first Vulvodynia Workshop: Current Knowledge and Future Direction. The goals of this conference were to bring together a multidisciplinary group of clinicians and researchers to exchange information on what was currently known about the disorder and to develop research priorities for the future .
In 1998, the National Institute of Child Health and Human Development (NICHD) issued its first Program Announcement on vulvodynia (PA-98-112): Vulvodynia - Systematic, Epidemiologic, Etiologic or Therapeutic Studies. (To read more about this PA, visit: http://grants2.nih.gov/grants/guide/pa-files/PA-98-112.html .) In early 2000, the NICHD and Office of Research on Women's Health issued the first Request for Applications (RFA:HD-00-008) on vulvodynia. Approximately $1 million was earmarked under this RFA, and many proposals were submitted and reviewed under both the RFA and PA. In late 2000, three studies were funded under the RFA and one was funded under the PA.
Details of the current Program Announcement can be viewed here: http://grants.nih.gov/grants/guide/pa-files/PA-07-182.html
Click Here for a summary of NIH funding mechanisms currently available.
Click on the underlined below to view a summary of the following NIH-funded studies:
Bernard L. Harlow, PhD
Harvard Medical School |
Prevalence And
Etiological Predictors Of Vulvodynia |
Barbara Reed, MD
University of Michigan |
Neuroimmunology/Cytokine
Alterations In Vulvodynia
Characterization of Pain Processing in Vulvodynia
Midcareer Vulvodynia Research and Mentoring Project
Longitudinal Population-Based Study of Vulvodynia |
Gloria Bachmann, MD
Robert Wood Johnson (UMDNJ) |
Vulvodynia Prevalence
And Efficacy Of 4 Interventions |
Robin Masheb, PhD
Yale University |
Cognitive-Behavioral
Therapy For Vulvodynia |
Ursula Wesselmann, MD, PhD
Johns Hopkins University |
Mechanisms of
Vulvodynia
|
David Foster, MD, MPH
University of Rochester |
Vulvar vestibulitis
trial: Desipramine-Lidocaine |
Denniz Zolnoun, MD
University of North Carolina |
Refining Diagnostic Criteria of a Pain Disorder: Vulvar Vestibulitis Syndrome |
Peter Smith, PhD
University of Kansas |
Female Pelvic Pain, Hormones and Neuroplasticity |
Colleen Kennedy, MD
University of Iowa |
|
| |
|
|
